Ackerman Joel reported grant involving 31,216 derivative units of CHAMPIONS ONCOLOGY, INC. at $4.76 for $149k on Nov 5, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 9, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$148,588.16Shares × reported price
Shares traded
31,216Option to purchase Common Stock
Price per share
$4.76Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
31,216Direct
Trade date
Nov 5, 2026Grant
Filed
Nov 9, 2026, 4:22 PM ET4-day reporting delay
Accession
0001628280-26-072233Code A · Transaction 395931
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CSBR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CSBR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago −0.8%1d ago −0.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2026, February 5, 2027, May 5, 2027 and August 5, 2027, respectively.